Two Accolades for MRC Career Development Fellow, Mootaz Salman

Trailblasing Research in Neurodegenerative Diseases

Mootaz Salman received two awards for his research in neurodegenerative diseases.

The Society for Experimental Biology (SEB) awarded him the 2024 President’s Medal for the Cell Biology Section, acknowledging his outstanding contributions to understanding the cell biology of the blood-brain barrier. Mootaz's research has advanced knowledge of neurodegenerative diseases and drug development.

In addition, Alzheimer’s Research UK presented Mootaz with the David Hague Early Career Investigator Award 2024, recognising him as an outstanding early career researcher in the field of biomedical dementia research. The award acknowledges Mootaz's excellence in scientific research and significant contributions to the field.

Mootaz, an MRC Career Development Fellow at the University of Oxford, expressed his gratitude for these awards, emphasising the inspiration he gained from mentors and colleagues. His research, focuses on investigating mechanisms of blood-brain barrier (dys)function in neurodegenerative diseases and employs cutting-edge technologies such as patient-derived stem cells, CRISPR-Cas9 gene editing, and organ-on-a-chip.

These awards recognise Mootaz's achievements and highlight the impact his work is making in advancing our understanding of neurodegenerative diseases.

Since April 2021, Oxford University's KAVLI Institute for Nanoscience Discovery is proudly serving as a hub for research groups from seven different departments spanning both the medical and physical sciences, including Salman Group from the Department of Physiology, Anatomy and Genetics.